taletrectinib
Drug Details
- Generic Name
- taletrectinib
- Brand Names
- IBTROZI
- Application Number
- NDA219713
- Sponsor
- Nuvation Bio Inc.
- NDC Codes
- 1
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- TALETRECTINIB ADIPATE
Indications and Usage
1 INDICATIONS AND USAGE IBTROZI ™ (taletrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC) [see Dosage and Administration ( 2.1 )] . IBTROZI is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC). ( 1 )